Borgwarner Inc SEC Filings

BorgWarner Inc. insider sale notice (Form 144) — This filing reports that an individual received 2,690 shares on 02/05/2025 from a performance stock lapse as equity compensation and intends to sell those 2,690 common shares on 08/28/2025 through Charles Schwab & Co., Inc. at an aggregate market value of $115,470 on the NYSE. The filing also discloses that the same person sold 5,000 shares on 08/04/2025 for $188,550 and 2,500 shares on 08/12/2025 for $100,025. The filer certifies no undisclosed material adverse information.

Isabelle McKenzie, Vice President of BorgWarner Inc. (BWA), reported a sale of common stock on 08/12/2025. She sold 2,500 shares at a weighted average price of approximately $40.0101, with actual prices ranging from $40.0101 to $40.0110. After the sale she beneficially owned 55,945 shares. The Form 4 was signed by Miyuki P. Oshima as attorney-in-fact on 08/14/2025. The filing shows a single, non-derivative disposition and does not include any additional commentary or plans.

Insider sales by BorgWarner director/officer Stefan Demmerle totaling 20,000 shares were reported. The Form 4 shows three separate sell transactions on 08/12/2025 and 08/13/2025: 5,000 shares at a weighted average price of $40.0437 (actual prices ranged $40.04–$40.05), 10,000 shares at $38.95, and 5,000 shares at $40.50. After these transactions the report lists the beneficial ownership balance as 229,039.69 shares (reported following the 08/13/2025 sale). The filing was submitted via attorney-in-fact and includes an explanation that the first sale price is a weighted average and that detailed per-price quantities are available on request.

Harris Associates L.P. and Harris Associates, Inc. report beneficial ownership of 2,772,856 shares of BorgWarner Inc. common stock, representing 1.3% of the class as of the reporting period. The filing states Harris has sole voting power over 2,757,981 shares and sole dispositive power over 2,772,856 shares. The document identifies the issuer's principal office in Auburn Hills, Michigan, and provides Harris’s business address in Chicago. The filing is a Schedule 13G amendment (cover indicates Amendment No. 1) and includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control. The statement is signed by Joseph J. Allessie as General Counsel and Secretary for both reporting entities with signature dates of 08/14/2025.

BorgWarner reported a Form 144 notice disclosing a proposed sale of 5,000 shares of its common stock with an aggregate market value of $202,500 and an approximate sale date of 08/13/2025. The shares were acquired on 02/28/2022 through the vesting of restricted stock units granted under the issuer's equity compensation plan. The filing lists 216,392,876 shares outstanding and identifies Merrill Lynch as the broker. The filing also reports prior sales by the same person of 20,000 shares on 08/04/2025 for $763,383.17 and 15,000 shares on 08/12/2025 for $589,718.34. The signer certifies they are unaware of undisclosed material adverse information.

Rule 144 notice to sell 15,000 shares of BorgWarner common stock is reported to be executed through Merrill Lynch with an aggregate market value of $589,718.34 and an approximate sale date of 08/12/2025. The filing reports 216,392,876 shares outstanding, so the block to be sold is a very small portion of total shares.

The securities were acquired under the issuer equity compensation plan via vesting of restricted stock units: 10,000 shares vested on 02/08/2019 and 5,000 shares vested on 02/06/2021. The filing also discloses that Stefan Demmerle sold 20,000 shares on 08/04/2025 for gross proceeds of $763,383.17.

The filer affirms, by signing the notice, that they do not know of any material adverse nonpublic information about the issuer not publicly disclosed.

BorgWarner filed a Form 144 reporting a proposed sale of 2,500 common shares to be executed through Charles Schwab on 08/12/2025 with an aggregate market value of $100,025, to be listed on the NYSE. The 2,500 shares equal approximately 0.001155% of the issuer's 216,392,876 shares outstanding, indicating the sale is immaterial to the company’s overall capitalization. The shares were acquired as equity compensation: 1,380 from a restricted stock lapse on 02/28/2020 and 1,120 from a performance stock lapse on 02/05/2025, which together match the 2,500 shares proposed for sale. The filing also discloses two prior dispositions in the past three months totaling 10,000 shares for aggregate proceeds of $354,800. The signer represents no known undisclosed material adverse information.

BorgWarner's Schedule 13G/A shows Victory Capital Management, Inc. beneficially owns 7,798,478 shares of common stock, equal to 3.55% of the class. Victory Capital reports sole voting power over 7,588,779 shares and sole dispositive power over 7,798,478 shares, and classifies itself as an investment adviser (IA). The filing includes a certification that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.